CRYM — Cryomass Technologies Share Price
0.000.00%
Last trade - 00:00- $8.75m
- $12.00m
- $0.01m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 689.14 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -92233.14% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.02 | 0.78 | n/a | n/a | 0.01 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cryomass Technologies Inc. develops and licenses cutting-edge equipment and processes to refine harvested cannabis, hemp, and other crops. The Company’s patented technology harnesses liquid nitrogen to reduce biomass and then efficiently isolate, collect, and preserve delicate resin glands (trichomes) containing prized compounds like cannabinoids and terpenes. Building on this technology, CryoMass has engineered its Trichome Separation unit (CryoSift Separator), optimized via patented cryogenic processes to rapidly capture intact, high-value cannabis and hemp trichomes (CryoSift). For cultivators, reducing biomass into CryoSift slashes volume up to 80%, dramatically lowering storage, handling, and transportation costs. CryoMass anticipates its efficiencies will catalyze industry-wide shifts in cannabis and hemp post- harvest methods. Its business portfolio includes the accounts of Cryomass LLC, Cryomass California LLC and 1304740 BC ULC doing business as Cryomass Canada.
Directors
- Delon Human NEC
- Christian Noel CEO (45)
- Pphilip Mullin CFO (68)
- Patricia Kovacevic GCN (51)
- Simon Langelier DRC
- Mario Gobbo IND (62)
- Mark Radke IND
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 10th, 2011
- Public Since
- November 26th, 2013
- No. of Shareholders
- 326
- No. of Employees
- 6
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 218,684,877
- Address
- 1001 BANNOCK STREET, SUITE 612, DENVER, 80204
- Web
- https://cryomass.com/
- Phone
- +1 3032228092
- Auditors
- Haynie & Co.
Upcoming Events for CRYM
Cryomass Technologies Inc Annual Shareholders Meeting
Q2 2024 Cryomass Technologies Inc Earnings Release
Q3 2024 Cryomass Technologies Inc Earnings Release
Similar to CRYM
3DX Industries
Pink Sheets on Nasdaq
420 Property Management
Pink Sheets on Nasdaq
Abb
Pink Sheets on Nasdaq
Abound Energy
Pink Sheets on Nasdaq
AI Technology.
Pink Sheets on Nasdaq
FAQ
What is the Cryomass Technologies share price?
As of Today at 20:10 UTC, shares in Cryomass Technologies are trading at $0.04. This share price information is delayed by 15 minutes.
How has the Cryomass Technologies share price performed this year?
Shares in Cryomass Technologies last closed at $0.04 and the price had moved by -62.63% over the past 365 days. In terms of relative price strength the Cryomass Technologies share price has underperformed the S&P500 Index by -68.63% over the past year.
What are the analyst and broker recommendations for Cryomass Technologies?
There is no consensus recommendation for this security.
What is the Cryomass Technologies dividend yield?
Cryomass Technologies does not currently pay a dividend.
Does Cryomass Technologies pay a dividend?
Cryomass Technologies does not currently pay a dividend.
When does Cryomass Technologies next pay dividends?
Cryomass Technologies does not currently pay a dividend.
How do I buy Cryomass Technologies shares?
To buy shares in Cryomass Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Cryomass Technologies?
As of the previous close price of $0.04, shares in Cryomass Technologies had a market capitalisation of $9.34m.
Where are Cryomass Technologies shares listed?
Here are the trading details for Cryomass Technologies:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CRYM
What kind of share is Cryomass Technologies?
Based on an overall assessment of its quality, value and momentum Cryomass Technologies is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Cryomass Technologies share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Cryomass Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cryomass Technologies. Over the past six months, its share price has outperformed the S&P500 Index by +46.47%.
As of the last closing price of $0.04, shares in Cryomass Technologies were trading -23.15% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Cryomass Technologies PE Ratio?
The Cryomass Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Cryomass Technologies?
Cryomass Technologies' management team is headed by:
- Delon Human - NEC
- Christian Noel - CEO
- Pphilip Mullin - CFO
- Patricia Kovacevic - GCN
- Simon Langelier - DRC
- Mario Gobbo - IND
- Mark Radke - IND